Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim analysis of the atezobladderpreserve phase II trial (SOGUG-2017-A-IEC(VEJ)-4)

被引：0

作者：

Calvo, Ovidio Fernandez

Bonfill, Teresa

Madueno, Francisca Martinez

Romero-Laorden, Nuria

Sequero-Lopez, Silvia

Domenech-Santasusana, Montserrat

Sevillano, Elena

Sanchez, Jose Garcia

Roman, Pilar Canoa

Alvarez-Fernandez, Carlos

Vazquez-Estevez, Sergio

机构：

[1] Complejo Hosp Univ Ourense, Med Oncol Dept, Orense, Spain

[2] Hosp Univ Parc Tauli, Sabadell, Spain

[3] HU St Joan Reus, Reus, Spain

[4] Hosp Univ Princesa, Madrid, Spain

[5] Hosp Univ San Cecilio, Granada, Spain

[6] Fundacio Althaia, Dept Med Oncol, Barcelona, Spain

[7] Fundacio Althaia, Dept Med Oncol, Manresa, Spain

[8] HM Sanchinarro Ctr Integral Oncol Clara CIOCC, Madrid, Spain

[9] Hosp Arnau Vilanova Valencia, Valencia, Spain

[10] Hosp Univ Lucus Augusti, Lugo, Spain

[11] Hosp Univ Cent Asturias, Med Oncol Dept, Oviedo, Spain

[12] Hosp Univ Lucus Augusti HULA, EOXI Lugo, Lugo, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4592

引用

页数：1

共 50 条

[1] Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim analysis of the ATEZOBLADDERPRESERVE phase II trial (SOGUG-2017-A-IEC(VEJ)-4).
Vazquez-Estevez, Sergio
Fernandez-Calvo, Ovidio
Bonfill-Abella, Teresa
Sequero, Silvia
Martinez-Madueno, Francisca
Romero-Laorden, Nuria
Domenech-Santasusana, Montserrat
Sevillano, Elena
Sanchez, Jose Garcia
Alvarez-Fernandez, Carlos
Nunez-Gonzalez, Cristina
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[2] Efficacy of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer (MIBC) (SOGUG-2017-A-IEC(VEJ)-4)
Vazquez-Estevez, Sergio
Fernandez Calvo, Ovidio
Alvarez-Fernandez, Carlos
Bonfill, Teresa
Domenech, Montserrat
GarcIa SAnchez, Jose
Jurado Garcia, Jose Miguel
Martinez Madueno, Francisca
Romero-Laorden, Nuria
Sevillano, Elena
Nunez, Cristina
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[3] Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer
Choudhury, Ananya
Swindell, Ric
Logue, John P.
Elliott, P. Anthony
Livsey, Jacqueline E.
Wise, Marcus
Symonds, Paul
Wylie, James P.
Ramani, Vijay
Sangar, Vijay
Lyons, Jeanette
Bottomley, Ian
McCaul, Damian
Clarke, Noel W.
Kiltie, Anne E.
Cowan, Richard A.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (06) : 733 - 738
[4] Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy as bladder-sparing therapy in patients with localized muscle invasive bladder cancer: A SOGUG study.
Cuellar, M. Andres
Medina, Ana
Girones, Regina
Valderrama, B. P.
Font, Albert
Juanfita, M. J.
de Velasco, Guillermo
Ferrer, Ferran
Vigues, Francesc
Garcia del Muro, Xavier
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[5] Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer
Marcq, Gautier
Souhami, Luis
Cury, Fabio L.
Salimi, Afsar
Aprikian, Armen
Tanguay, Simon
Vanhuyse, Marie
Rajan, Raghu
Brimo, Fadi
Mansure, Jose Joao
Kassouf, Wassim
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (03): : 738 - 741
[6] Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
Funt, Samuel A.
Lattanzi, Michael
Whiting, Karissa
Al-Ahmadie, Hikmat
Quinlan, Colleen
Teo, Min Yuen
Lee, Chung-Han
Aggen, David
Zimmerman, Danielle
McHugh, Deaglan
Apollo, Arlyn
Durdin, Trey D.
Truong, Hong
Kamradt, Jeffrey
Khalil, Maged
Lash, Bradley
Ostrovnaya, Irina
McCoy, Asia S.
Hettich, Grace
Regazzi, Ashley
Jihad, Marwah
Ratna, Neha
Boswell, Abigail
Francese, Kaitlyn
Yang, Yuanquan
Folefac, Edmund
Herr, Harry W.
Donat, S. Machele
Pietzak, Eugene
Cha, Eugene K.
Donahue, Timothy F.
Goh, Alvin C.
Huang, William C.
Bajorin, Dean F.
Iyer, Gopa
Bochner, Bernard H.
Balar, Arjun V.
Mortazavi, Amir
Rosenberg, Jonathan E.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) : 1312 - +
[7] A phase II study investigating the safety and efficacy of neoadjuvent atezolizumab in muscle invasive bladder cancer (ABACUS)
Castellano, D.
Duran, I.
Rodriguez-Vida, A.
Crabb, S. J.
van der Heijden, M. S.
Font Pous, A.
Gravis, G.
Anido Herranz, U.
Protheroe, A.
Ravaud, A.
Maillet, D.
Mendez-Vidal, M. J.
Suarez, C.
Lorch, A.
Sternberg, C. N.
Linch, M.
Sarker, S-J.
Notta, J.
Mousa, K.
Powles, T. B.
ANNALS OF ONCOLOGY, 2018, 29 : 319 - 319
[8] A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).
Powles, Thomas
Rodriguez-Vida, Alejo
Duran, Ignacio
Crabb, Simon J.
Van der Heijden, Michiel Simon
Pous, Albert Font
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[9] A multicentre NCRI phase II study of hypofractionated conformal radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer
Choudhury, A.
Swindell, R.
Logue, J. P.
Kiltie, A. E.
Clarke, N. W.
Cowan, R. A.
BJU INTERNATIONAL, 2010, 106 (01) : 8 - 8
[10] Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial
Garcia-del-Muro, Xavier
P. Valderrama, Begona
Medina-Colmenero, Ana
Etxaniz, Olatz
Sarrio, Regina Girones
Juan-Fita, Maria Jose
Costa-Garcia, Marcel
Moreno, Rafael
Rodriguez, Isabel Miras
Ortiz, Irene
Cuellar, Andres
Ferrer, Ferran
Vigues, Francesc
de Haro Piedra, Roberto
Candal Gomez, Arturo
Villa, Salvador
Pontones, Jose Luis
Murria, Yasmina
Lendinez-Cano, Guillermo
Alemany, Ramon
CLINICAL CANCER RESEARCH, 2025, 31 (04) : 659 - 666

← 1 2 3 4 5 →